FR3048359B1 - Utilisation d’au moins un filtre uva long pour prevenir l’apparition de sensations dysesthesiques - Google Patents

Utilisation d’au moins un filtre uva long pour prevenir l’apparition de sensations dysesthesiques Download PDF

Info

Publication number
FR3048359B1
FR3048359B1 FR1651729A FR1651729A FR3048359B1 FR 3048359 B1 FR3048359 B1 FR 3048359B1 FR 1651729 A FR1651729 A FR 1651729A FR 1651729 A FR1651729 A FR 1651729A FR 3048359 B1 FR3048359 B1 FR 3048359B1
Authority
FR
France
Prior art keywords
once
prevent
uva filter
sensations
long uva
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1651729A
Other languages
English (en)
Other versions
FR3048359A1 (fr
Inventor
Laurent Marrot
Jean Philippe Belaidi
Laurence Denat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1651729A priority Critical patent/FR3048359B1/fr
Publication of FR3048359A1 publication Critical patent/FR3048359A1/fr
Application granted granted Critical
Publication of FR3048359B1 publication Critical patent/FR3048359B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne l'utilisation cosmétique d'au moins un filtre UV-A long pour prévenir l'apparition de sensations dysesthésiques. La présente invention vise principalement à proposer un nouvel actif pour prévenir l'apparition de sensations dysesthésiques.
FR1651729A 2016-03-01 2016-03-01 Utilisation d’au moins un filtre uva long pour prevenir l’apparition de sensations dysesthesiques Active FR3048359B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1651729A FR3048359B1 (fr) 2016-03-01 2016-03-01 Utilisation d’au moins un filtre uva long pour prevenir l’apparition de sensations dysesthesiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1651729A FR3048359B1 (fr) 2016-03-01 2016-03-01 Utilisation d’au moins un filtre uva long pour prevenir l’apparition de sensations dysesthesiques

Publications (2)

Publication Number Publication Date
FR3048359A1 FR3048359A1 (fr) 2017-09-08
FR3048359B1 true FR3048359B1 (fr) 2020-11-06

Family

ID=56555458

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1651729A Active FR3048359B1 (fr) 2016-03-01 2016-03-01 Utilisation d’au moins un filtre uva long pour prevenir l’apparition de sensations dysesthesiques

Country Status (1)

Country Link
FR (1) FR3048359B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003250866B2 (en) * 2002-07-10 2008-10-02 Ciba Holding Inc. Merocyanine derivatives for cosmetic use
GB2433499A (en) * 2005-12-20 2007-06-27 Ciba Sc Holding Ag Merocyanine derivatives useful as UV absorbing agents
FR2967065A1 (fr) * 2010-11-09 2012-05-11 Oreal Utilisation d'extrait de grenade pour prevenir et/ou traiter les sensations dysesthesiques des peaux et/ou des cuirs chevelus intolerants et/ou irritables
WO2013010590A1 (fr) * 2011-07-21 2013-01-24 L'oreal Composition cosmétique et/ou dermatologique contenant un dérivé de mérocyanine qui comprend des groupes polaires spécifiques constitués de fonctionnalités hydroxyle et éther

Also Published As

Publication number Publication date
FR3048359A1 (fr) 2017-09-08

Similar Documents

Publication Publication Date Title
MX2022000711A (es) Inhibidores de parp1.
JOP20200209A1 (ar) مثبطات cd73
CL2019003126A1 (es) Métodos de tratamiento mediante el uso de un compuesto inhibidor de jak.
MX2022009309A (es) Compuestos y usos de los mismos.
AR111208A1 (es) ANTICUERPOS ANTI-PÉPTIDO b AMILOIDE N3PGLU Y SUS USOS
EA201891620A1 (ru) Ингибиторы взаимодействующей с рецептором протеинкиназы 1
MX390083B (es) Formulaciones de (r)-2-amino-3-fenilpropil carbamato.
MA67726B1 (fr) Utilisations thérapeutiques de dérivés deutérés du lanifibranor
MA42109A (fr) Amides hétérocycliques utilisés en tant qu'inhibiteurs de kinase
EA201790271A1 (ru) Ингибиторы гликозидазы
MX380589B (es) Métodos de tratamiento y prevencion de la disfunción endotelial utilizando metil bardoxolona o sus análogos.
MX384833B (es) Inhibidores de tirosina quinasa de bruton
MA50013A (fr) Analogues de benzoazépine utilisés en tant qu'agents inhibiteurs de la tyrosine kinase de bruton
MA47736B1 (fr) Pyrimidopyrimidinones utiles en tant qu'inhibiteurs de la kinase wee-1
MA47356A1 (fr) Dérivés d'isochromène utiles en tant qu'inhibiteurs des phosphoinositide 3-kinases
EA201992170A1 (ru) Модуляторы экспрессии pcsk9
EA202092748A1 (ru) Модуляторы экспрессии apol1
EA202191175A1 (ru) Сконструированные с цистеином конъюгаты антитело-лекарственное средство, содержащие пептидсодержащие линкеры
MX2019010707A (es) Metodos para tratar y/o prevenir queratosis actinica.
CL2019003037A1 (es) Combinaciones fungicidas.
MA41809A (fr) Biotine pour le traitement de la sclérose latérale amyotrophique
EP4389214A3 (fr) Utilisation du trimethoxybenzyl acetylsinapate, avantageusement en combinaison avec au moins un filtre solaire, pour la protection de la peau
MX2020011814A (es) Anticuerpo anti-tlr7 humano.
FR3078261B1 (fr) Hydrogel pour stimuler la neurotisation, l'osteogenese et l'angiogenese
FR3060376B1 (fr) Agent et procede pour la mise en forme temporaire de fibres keratiniques

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20170908

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11